Format

Send to

Choose Destination
Vaccine. 2017 Jul 13;35(32):4022-4028. doi: 10.1016/j.vaccine.2017.05.062. Epub 2017 Jun 16.

Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP∼T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea.

Author information

1
Korea University Ansan Hospital, Ansan, Republic of Korea.
2
Sanofi Pasteur, France.
3
Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
4
Cheil General Hospital & Women's Healthcare Center, Dankook University College of Medicine, Seoul, Republic of Korea.
5
Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Republic of Korea.
6
Kyung Hee University Hospital, Seoul, Republic of Korea.
7
Changwon Fatima Hospital, Changwon, Republic of Korea.
8
Korea Cancer Center Hospital, Seoul, Republic of Korea.
9
Hanil General Hospital, Seoul, Republic of Korea.
10
Pusan National University Children's Hospital, Yangsan, Republic of Korea.
11
Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
12
Wonkwang University School of Medicine & Hospital, Iksan, Republic of Korea.
13
Yonsei University Health System, Seoul, Republic of Korea.
14
Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
15
St. Vincent's Hospital, The Catholic University of Korea, Suwon, Republic of Korea. Electronic address: jh00mn@catholic.ac.kr.
16
Samsung Medical Center, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea.
17
Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Republic of Korea.
18
Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon, Republic of Korea.
19
Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
20
Sanofi Pasteur, Republic of Korea.
21
Sanofi Pasteur, Singapore.
PMID:
28629923
DOI:
10.1016/j.vaccine.2017.05.062
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center